Drug Pipeline

Cirtuvivint Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07032285 Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas Soft Tissue Sarcoma (STS) Recruiting
Phase 1
NCT06856499 Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination… Endometrioid Ovarian Cancer Recruiting
NCT06484062 Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve… Acute Myeloid Leukemia Recruiting
Sponsors Running Cirtuvivint Trials
National Cancer Institute (NCI) (1) University of Colorado, Denver (1) Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas (1)
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1) Ovarian Cancer (1) Sarcoma (1)
Get alerts when Cirtuvivint trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free